Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Galapagos NV ADR (NQ: GLPG ) 27.58 -0.59 (-2.09%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 6, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 150,952 Open 28.11 Bid (Size) 24.59 (1) Ask (Size) 29.07 (1) Prev. Close 28.17 Today's Range 27.54 - 28.30 52wk Range 24.16 - 42.45 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Why Trip.com Group Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket August 27, 2024 Via Benzinga Major Investor Says Galapagos Is 'Undervalued,' Plans To Push On Company's 'Performance' And 'Strategic Opportunities' August 26, 2024 Galapagos stock rises as EcoR1 Capital discloses a 9.9% stake and plans to engage on business and governance. Investor sees shares as deeply undervalued despite challenges, with new focus on CAR-T... Via Benzinga Performance YTD -33.28% -33.28% 1 Month +5.43% +5.43% 3 Month +3.06% +3.06% 6 Month -19.99% -19.99% 1 Year -25.98% -25.98% More News Read More Galapagos Surges On An FDA Win For Its Rival To Gilead, Novartis; But There Are Some Caveats August 26, 2024 Via Investor's Business Daily Exposures Product Safety Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday August 26, 2024 Via Benzinga 8 Analysts Have This to Say About Galapagos July 17, 2023 Via Benzinga Where Galapagos Stands With Analysts June 12, 2023 Via Benzinga JP Morgan Maintains Neutral Rating for Galapagos: Here's What You Need To Know May 31, 2023 Via Benzinga Earnings Outlook For Galapagos May 03, 2023 Via Benzinga Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket August 26, 2024 Via Benzinga FDA Approves Adaptimmune Therapeutics' Engineered Cell Therapy As First For Solid Tumor And New Therapy For Rare Soft Tissue Cancer In Over A Decade August 02, 2024 Via Benzinga Exposures Product Safety GLPG Stock Earnings: Galapagos Beats EPS, Beats Revenue for Q2 2024 August 01, 2024 Via InvestorPlace GLPG Stock Earnings: Galapagos Beats EPS, Misses Revenue for Q1 2024 June 25, 2024 Via InvestorPlace Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune's TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer and Potential Future Solid Tumor Indications May 30, 2024 Via Newsfile Earnings Preview For Galapagos February 23, 2023 Via Benzinga Galapagos Downgraded, Pharma Firm Faces Uphill Battle With Slow Pipeline Progress: Analyst April 01, 2024 Via Benzinga Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline February 22, 2024 From Frontier Medicines Via GlobeNewswire European Drugmaker Galapagos Collaborates With Biotech BridGene Biosciences To Develop Cancer Treatments January 03, 2024 Via Benzinga GLPG Stock Earnings: Galapagos Beats EPS, Beats Revenue for Q3 2023 December 13, 2023 Via InvestorPlace Benzinga's Top Ratings Upgrades, Downgrades For May 8, 2023 May 08, 2023 Via Benzinga BigCommerce, ContextLogic And Other Big Stocks Moving Lower In Friday's Pre-Market Session February 24, 2023 Via Benzinga Galapagos' Blood Cancer Candidate Shows 100% Objective Response Rate In Relapsed/Refractory Patients February 10, 2023 Via Benzinga Why Galapagos Stock Is Falling Today February 09, 2023 Via Benzinga Twitter Rolls Out 'Blue For Business,' Visa Pitches Auto-Payments On Ethereum Blockchain, Justin Bieber Slams H&M: Today's Top Stories December 20, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For January 23, 2023 January 23, 2023 Via Benzinga On A Mission As Top European Player, Galapagos Looks For Acquisition Targets December 20, 2022 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
